Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230107004
TCTR20230107004
Not yet recruiting
Phase 2

The efficacy of trisodium citrate versus heparin for permanent cuffed tunneled catheter lock in chronic hemodialysis patients

Faculty of Medicine Siriraj Hospital, Mahidol University0 sites148 target enrollmentJanuary 7, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionschronic hemodialysislocking solutioncitratepermanent catheterhemodialysis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
chronic hemodialysis
Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Enrollment
148
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 7, 2023
End Date
February 28, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Chronic hemodialysis patients via tunneled\-cuffed catheter
  • •2\. Newly inserted tunneled\-cuffed catheter for hemodialysis at right internal jugular vein
  • •3\. Age more than 18 years

Exclusion Criteria

  • •1\. Patients that refuse to give consent
  • •2\. Previously diagnosis of heparin induced thrombocytopenia
  • •3\. Severe liver impairment
  • •4\. Patients on cardiac pacemaker or with uncontrolled cardiac arrhythmia
  • •5\. Serum calcium less than 8\.4 mg/dl within 2 months before enrollment
  • •6\. Patients currently on systemic anticoagulant
  • •7\. History of allergy to heparin or trisodium citrate
  • •8\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters: a randomised controlled trial
ISRCTN27307877Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Enrolling By Invitation
Not Applicable
Efficacy of 5%, 10% trisodium citrate and heparin as catheter-locking solution for central venous hemodialysis catheters: A prospective randomized studyThe patients who need hemodialysis catheter insertionCatheter locking solutionHeparinTrisodium citrateHemodialysis catheter
TCTR20170314002Pattharawin Pattharanitima249
Recruiting
Phase 4
Efficacy of 5% Trisodium Citrate and Low Dose Heparin as Catheter-Locking Solution for Central Venous Hemodialysis Catheters: A Randomized Controlled StudyCentral venous catheter dysfunction (CVC dysfunction) is failure to maintain the prescribed extracorporeal blood flow required for adequate hemodialysis without lengthening the prescribed HD treatment. A catheter locking anticoagulant (CLA) by trisodium citrate (TSC) or unfractionated heparin (UFH) is recommended in real practice to prevent this problem.Central venous catheter dysfunction, CVC dysfunction, Catheter locking anticoagulant, CLA, Trisodium citrate, TSC, Unfractionated heparin, UFH
TCTR20231106002Thammasat University Research Fund216
Completed
Phase 2
Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous cathetersCVA.G90.3
IRCT2014050613156N5Vice Chancellor for reaserch Mazandaran University of Medical science84
Active, not recruiting
Phase 1
Investigating different anticoagulants for renal replacement therapy
EUCTR2014-004854-33-DEniversity Hospital Muenster1,450